10-Q: AXT Inc. Reports Strong Q1 2026 Revenue Growth
Quarterly Report
AXT Inc. announced a significant 39.1% year-over-year revenue increase in Q1 2026, driven by strong demand for Indium Phosphide substrates.
Summary
- AXT Inc. reported a 39.1% increase in total revenue for the first quarter of 2026, reaching $26.9 million compared to $19.4 million in the same period of 2025.
- The growth was primarily driven by a 74.0% surge in substrate revenue, totaling $19.3 million, attributed to higher demand for Indium Phosphide (InP) wafer substrates used in data center applications and passive optical networks, supported by new export approvals from China.
- Raw material sales decreased by 7.6% to $7.6 million, mainly due to weaker market demand for refined gallium, partially offset by increased sales of pBN crucibles.
- Gross profit improved significantly to $8.0 million from a loss of $1.2 million in the prior year's quarter, with gross profit margin increasing from -6.4% to 29.6%.
- Selling, general, and administrative expenses increased by 10.7% to $6.6 million, while research and development expenses decreased slightly by 3.4% to $3.0 million.
- The company reported a net loss attributable to AXT, Inc. of $1.6 million ($0.03 per diluted share) for Q1 2026, an improvement from a net loss of $8.8 million ($0.20 per diluted share) in Q1 2025.
- Cash and cash equivalents decreased significantly by $70.5 million during the quarter, primarily due to investing activities, while financing activities provided $8.0 million in net cash.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive filing due to significant revenue and gross profit improvements, driven by strong demand in key product areas. However, the ongoing geopolitical risks, export permit uncertainties, and decrease in cash reserves temper the overall sentiment.
Positives
- Significant revenue growth of 39.1% year-over-year, reaching $26.9 million.
- Substrate revenue increased by 74.0% to $19.3 million, driven by strong demand for InP substrates.
- Gross profit turned positive, reaching $8.0 million from a loss of $1.2 million in the prior year.
- Gross profit margin improved substantially from -6.4% to 29.6%.
- Increased revenue in Europe (172.4%) and Asia Pacific (179.5%) due to export approvals.
- Interest income improved significantly due to proceeds from a recent public offering.
- Equity in income from unconsolidated joint ventures increased by 42.3%.
Negatives
- Raw material sales decreased by 7.6% due to weaker demand for refined gallium.
- Revenue in North America decreased by 81.3% due to China export restrictions and lower demand for pBN crucibles.
- Net loss attributable to AXT, Inc. was $1.6 million.
- Cash and cash equivalents decreased by $70.5 million during the quarter.
- The company faces ongoing challenges with China export permit applications for indium phosphide substrates, creating uncertainty for customers and operations.
- Significant increase in provision for income taxes by 481.1%.
Risks
- Escalating trade tariffs, import/export restrictions, and Chinese regulations could materially harm the business.
- The company's reliance on China for manufacturing exposes it to risks from changes in Chinese political, social, regulatory, or economic environments.
- Potential for mandatory factory shutdowns in China due to environmental regulations or air pollution.
- The cyclical nature of the semiconductor industry may limit the ability to maintain or increase net sales and operating results during downturns.
- Product qualification cycles are long, making it difficult to forecast revenue from new customers or products.
- Defects in products could diminish demand and lead to customer dissatisfaction, lost sales, and reputational damage.
- Dependence on a limited number of suppliers for critical raw materials and equipment.
- Uncertainty regarding the United States foreign policy, particularly with regards to China, could disrupt business.
- The potential failure of Tongmei's IPO on the STAR Market could lead to investor redemption rights and a need for additional capital.
- Litigation and legal proceedings, including a shareholder class action and a derivative lawsuit, could adversely affect the business.
Future Outlook
The company intends to use proceeds from recent offerings to support Tongmei's capacity expansion for indium phosphide substrates, fund research and development, and for general corporate purposes. Pending these uses, proceeds will be invested in capital preservation instruments. The company believes it has adequate cash and investments for the next 12 months, but acknowledges that a sales decrease could impact liquidity and necessitate seeking additional capital.
Management Comments
- The increase in gross profit is attributed to higher revenue resulting in fixed costs being spread over more units and a favorable change in product mix.
- The higher selling, general and administrative expenses were primarily from an increase in compensation related costs, travel related costs and legal expenses.
- The decrease in research and development expenses was primarily due to a decrease in compensation related costs, partially offset by the increased use of certain materials for new product development.
- Interest income increased primarily due to higher interest income resulting from proceeds from our secondary public offering in the gross amount of $100 million in December 2025.
- Other income, net decreased primarily due to foreign currency exchange losses in the current period compared to foreign currency exchange gains in the prior period.
- The tax expense recorded for the three months ended March 31, 2026 is the result of mainly foreign taxes, federal income taxes, and some minimum state taxes.
- Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests increased primarily due to higher profitability from our PRC subsidiaries as sales increased.
Industry Context
StockSavvy.ai notes that AXT's strong revenue growth in InP substrates aligns with the increasing demand for high-speed data transfer driven by AI applications and data center connectivity, a key trend in the semiconductor industry. However, the significant decrease in North American revenue highlights the ongoing impact of geopolitical trade tensions and China's export control regulations on global supply chains.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Audit Committee Composition | Following the passing of director Christine Russell, the Audit Committee was temporarily non-compliant with Nasdaq listing rules. Mr. Leonard J. LeBlanc was appointed as a non-independent member and later determined to be independent, restoring compliance. Mr. LeBlanc was appointed Chair of the Audit Committee. | January 26, 2026 | Regained compliance with Nasdaq listing rules for audit committee independence. |
Legal Proceedings
- A putative shareholder class action complaint was filed alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Defendants' motion to dismiss is pending.
- A derivative lawsuit was filed against officers and directors, alleging breach of fiduciary duties. The plaintiff appealed the court's dismissal of the case.
Related Party Transactions
- Funding received by consolidated subsidiary ChaoYang XinMei from minority investors and Tongmei in 2021 and 2022.
- Sale of land and buildings by ChaoYang LiMei to equity investment entity ChaoYang KaiMei in September 2022.
- The company's executive officers retain board seats on the boards of companies in which it has invested in its PRC joint ventures.
Stakeholder Impact
- Shareholders may benefit from the strong revenue growth and improved gross profit, but face risks from geopolitical tensions, export controls, and potential stock price volatility.
- Customers may experience continued uncertainty regarding export permits for indium phosphide substrates, potentially impacting supply chain reliability.
- Employees may be impacted by increased administrative burdens related to export compliance and potential future restructuring.
Next Steps
- Continue to monitor and manage China export permit applications for indium phosphide substrates.
- Utilize proceeds from recent offerings to increase manufacturing capacity for indium phosphide substrates.
- Invest in research and development for new or improved products.
- Manage working capital and general corporate purposes.
- Continue to monitor global economic and political conditions, including trade tariffs and restrictions.
Key Dates
| Date | Description |
|---|---|
| 2020-12-31 | Reorganization of entity structures in China; JinMei and BoYu assigned to Tongmei. |
| 2021-01-25 | Chinese government approved approximately $49 million investment in Tongmei. |
| 2021-09-01 | ChaoYang XinMei received funding from a minority investor. |
| 2021-10-01 | ChaoYang XinMei received funding from a minority investor. |
| 2021-12-01 | ChaoYang XinMei received funding from Tongmei. |
| 2022-01-01 | ChaoYang XinMei received funding from Tongmei. |
| 2022-04-01 | ChaoYang JinMei signed a joint venture agreement with certain investor to fund ChaoYang ShuoMei. |
| 2022-04-01 | Tongmei signed a joint venture agreement with certain investors to fund ChaoYang KaiMei. |
| 2022-07-01 | Tongmei and minority investors further invested in ChaoYang XinMei. |
| 2022-07-12 | Shanghai Stock Exchange approved Tongmei's IPO application. |
| 2022-08-01 | CSRC accepted for review Tongmei's IPO application. |
| 2023-09-30 | Entered into an agreement to extend the lease for the Fremont facility. |
| 2024-01-30 | One subsidiary secured a new line of credit amounting to $9.7 million. |
| 2024-05-06 | Putative shareholder class action complaint filed. |
| 2024-08-22 | Derivative lawsuit filed. |
| 2025-02-18 | Compensation Committee certified year-over-year annual revenue growth rate for fiscal year 2024. |
| 2025-02-20 | Compensation Committee approved grant of at-risk, performance shares to Dr. Morris Young and Gary Fischer. |
| 2025-03-17 | Court granted motion to dismiss derivative lawsuit. |
| 2025-03-31 | End of the first fiscal quarter. |
| 2025-04-11 | Plaintiff filed notice of intent not to further amend complaint in derivative lawsuit. |
| 2025-04-14 | Court entered judgment on derivative lawsuit. |
| 2025-05-13 | Plaintiffs appealed to the Court of Appeals for the Ninth Circuit. |
| 2025-11-07 | Filed a registration statement on Form S-3. |
| 2025-11-27 | Registration statement on Form S-3 became effective. |
| 2025-12-03 | China issued further rules restricting exports of certain materials. |
| 2025-12-27 | Standing Committee of the National Peoples Congress of China enacted revisions to the Foreign Trade Law. |
| 2025-12-29 | Filed a prospectus supplement relating to an offering of common stock. |
| 2025-12-30 | Closing of the December Offering. |
| 2026-01-01 | Effective date for certain provisions of the revised Foreign Trade Law of the Peoples Republic of China. |
| 2026-01-26 | Board determined Mr. LeBlanc is independent under Nasdaq Listing Rules. |
| 2026-01-30 | Received notification from Nasdaq Listing Qualifications Department regarding regained compliance. |
| 2026-02-01 | United States increased tariff on imports of many products from China. |
| 2026-02-20 | U.S. Supreme Court invalidated many global tariffs. |
| 2026-02-24 | IEEPA-based tariff provisions terminated. |
| 2026-03-01 | Revisions to the Foreign Trade Law of the Peoples Republic of China effective. |
| 2026-03-04 | United States further increased tariff on imports of many products from China. |
| 2026-03-31 | End of the first fiscal quarter. |
| 2026-04-20 | Filed an automatic registration statement on Form S-3. |
| 2026-04-21 | Entered into an underwriting agreement with Northland Securities, Inc. |
| 2026-04-22 | Underwriters exercised their option to purchase additional shares. |
| 2026-05-14 | Date of filing of the Form 10-Q. |
Recommendation
holdAXT has demonstrated significant operational improvements with strong revenue growth and a return to profitability in gross margin. However, the persistent risks associated with China's export controls, geopolitical trade tensions, and the inherent cyclicality of the semiconductor industry warrant a cautious approach. While the company has successfully raised substantial capital, the uncertainties surrounding export permits for key products like InP substrates create a level of risk that prevents a strong buy recommendation at this time. A 'hold' position allows investors to monitor the resolution of these geopolitical and regulatory challenges while benefiting from the company's operational progress.
Keywords
AXT Inc., Form 10-Q, Quarterly Report, Indium Phosphide, Gallium Arsenide, Germanium, Semiconductor Substrates, China Export Controls, Tariffs, Revenue Growth, Gross Profit, Net Loss, Financial Results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.